181 related articles for article (PubMed ID: 7915608)
1. Enhancement of noradrenergic constriction of large coronary arteries by inhibition of nitric oxide synthesis in anaesthetized dogs.
Woodman OL; Pannangpetch P
Br J Pharmacol; 1994 Jun; 112(2):443-8. PubMed ID: 7915608
[TBL] [Abstract][Full Text] [Related]
2. Endothelium-dependent relaxation competes with alpha 1- and alpha 2-adrenergic constriction in the canine epicardial coronary microcirculation.
Jones CJ; DeFily DV; Patterson JL; Chilian WM
Circulation; 1993 Apr; 87(4):1264-74. PubMed ID: 8384938
[TBL] [Abstract][Full Text] [Related]
3. N-nitro L-arginine causes coronary vasoconstriction and inhibits endothelium-dependent vasodilatation in anaesthetized greyhounds.
Woodman OL; Dusting GJ
Br J Pharmacol; 1991 Jun; 103(2):1407-10. PubMed ID: 1909199
[TBL] [Abstract][Full Text] [Related]
4. The role of alpha 1- and alpha 2-adrenoceptors in the coronary vasoconstrictor responses to neuronally released and exogenous noradrenaline in the dog.
Woodman OL
Naunyn Schmiedebergs Arch Pharmacol; 1987 Aug; 336(2):161-8. PubMed ID: 2891038
[TBL] [Abstract][Full Text] [Related]
5. Attenuation of vasoconstriction by endogenous nitric oxide in rat caudal artery.
Vo PA; Reid JJ; Rand MJ
Br J Pharmacol; 1992 Dec; 107(4):1121-8. PubMed ID: 1467834
[TBL] [Abstract][Full Text] [Related]
6. NG-nitro-L-arginine antagonizes endothelium-dependent dilator responses by inhibiting endothelium-derived relaxing factor release in the isolated rabbit heart.
Lamontagne D; Pohl U; Busse R
Pflugers Arch; 1991 Apr; 418(3):266-70. PubMed ID: 1649992
[TBL] [Abstract][Full Text] [Related]
7. Endothelial function and adrenergic reactivity in human type-II diabetic resistance arteries.
Cipolla MJ; Harker CT; Porter JM
J Vasc Surg; 1996 May; 23(5):940-9. PubMed ID: 8667520
[TBL] [Abstract][Full Text] [Related]
8. The effects of cross-linked hemoglobin on regional vascular conductance in dogs.
Dietz NM; Martin CM; Beltran-del-Rio AG; Joyner MJ
Anesth Analg; 1997 Aug; 85(2):265-73. PubMed ID: 9249098
[TBL] [Abstract][Full Text] [Related]
9. Involvement of nitric oxide in coronary vascular responses to 5-hydroxytryptamine in the anaesthetized greyhound.
Woodman OL; Dusting GJ
Clin Exp Pharmacol Physiol; 1994 May; 21(5):377-81. PubMed ID: 7525131
[TBL] [Abstract][Full Text] [Related]
10. Functional relation between nitric oxide and noradrenaline for the modulation of vascular tone in rat mesenteric vasculature.
Yamamoto R; Wada A; Asada Y; Yuhi T; Yanagita T; Niina H; Sumiyoshi A
Naunyn Schmiedebergs Arch Pharmacol; 1994 Apr; 349(4):362-6. PubMed ID: 8058108
[TBL] [Abstract][Full Text] [Related]
11. Cerebral blood flow and cerebrovascular reactivity after inhibition of nitric oxide synthesis in conscious goats.
Fernández N; García JL; García-Villalón AL; Monge L; Gómez B; Diéguez G
Br J Pharmacol; 1993 Sep; 110(1):428-34. PubMed ID: 8220904
[TBL] [Abstract][Full Text] [Related]
12. Contribution of nitric oxide to coronary vasodilation during hypercapnic acidosis.
Gurevicius J; Salem MR; Metwally AA; Silver JM; Crystal GJ
Am J Physiol; 1995 Jan; 268(1 Pt 2):H39-47. PubMed ID: 7530920
[TBL] [Abstract][Full Text] [Related]
13. The effect of the carotid sinus reflex on large coronary artery diameter in anaesthetized dogs.
Woodman OL
Clin Exp Pharmacol Physiol; 1987; 14(11-12):867-75. PubMed ID: 2896081
[TBL] [Abstract][Full Text] [Related]
14. The role of endothelium-derived nitric oxide in acetylcholine-induced coronary vasoconstriction in closed-chest pigs.
Hata H; Egashira K; Fukai T; Ohara Y; Kasuya H; Takahashi T; Takeshita A
Coron Artery Dis; 1993 Oct; 4(10):891-8. PubMed ID: 8269195
[TBL] [Abstract][Full Text] [Related]
15. Role of EDRF/NO in parasympathetic coronary vasodilation following carotid chemoreflex activation in conscious dogs.
Shen W; Ochoa M; Xu X; Wang J; Hintze TH
Am J Physiol; 1994 Aug; 267(2 Pt 2):H605-13. PubMed ID: 7915084
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular actions of inhibitors of endothelium-derived relaxing factor (nitric oxide) formation/release in anesthetized dogs.
Klabunde RE; Ritger RC; Helgren MC
Eur J Pharmacol; 1991 Jun; 199(1):51-9. PubMed ID: 1893927
[TBL] [Abstract][Full Text] [Related]
17. A comparison of the inhibitory effects of sodium nitroprusside, pinacidil and nifedipine on pressor response to NG-nitro-L-arginine.
Wang YX; Zhou T; Pang CC
Br J Pharmacol; 1993 Feb; 108(2):398-404. PubMed ID: 8448590
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of nitric oxide synthase specifically enhances adrenergic vasoconstriction in rabbits.
Du ZY; Dusting GJ; Woodman OL
Clin Exp Pharmacol Physiol; 1992 Jul; 19(7):523-30. PubMed ID: 1379894
[TBL] [Abstract][Full Text] [Related]
19. Assessment of ability of levcromakalim and sodium nitroprusside to reverse the cardiovascular effects of nitric oxide synthase inhibition in the anaesthetised pig.
Herity NA; Allen JD; Silke B; Adgey AA
Cardiovasc Res; 1994 Jun; 28(6):894-900. PubMed ID: 7522965
[TBL] [Abstract][Full Text] [Related]
20. Effects of nitric oxide synthesis inhibition on the goat coronary circulation under basal conditions and after vasodilator stimulation.
García JL; Fernández N; García-Villalón AL; Monge L; Gómez B; Diéguez G
Br J Pharmacol; 1992 Jul; 106(3):563-7. PubMed ID: 1504740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]